Abstract:RNA polymerase II (Pol II) carboxyl‐terminal domain (CTD) is phosphorylated at its Threonine 4 (Thr4) residue by canonical and non‐canonical CTD kinases in a signal‐responsive and gene‐specific manner. In addition to roles in transcriptional elongation and termination, phospho‐Thr4 (pT4) marks dictate unique known and as‐of‐yet hidden functions in RNA Pol II regulation. The largest subunit of RNA polymerase II (Pol II) has an unusual carboxyl‐terminal domain (CTD). This domain is composed of a tandemly repeating heptapeptide, Y1S2P3T4S5P6S7, that has multiple roles in regulating Pol II function and processing newly synthesized RNA. Transient phosphorylation of Ser2 and Ser5 of the YS2PTS5PS repeat have well‐defined roles in recruiting different protein complexes and coordinating sequential steps in gene transcription. As such, these phospho‐marks encipher a molecular recognition code, colloquially termed the CTD code. In contrast, the contribution of phospho‐Threonine 4 (pThr4/pT4) to the CTD code remains opaque and contentious. Fuelling the debate on the relevance of this mark to gene expression are the findings that replacing Thr4 with a valine or alanine has varied impact on cellular function in different species and independent proteomic analyses disagree on the relative abundance of pThr4 marks. Yet, substitution with negatively charged residues is lethal and even benign mutations selectively disrupt synthesis and 3′ processing of distinct sets of coding and non‐coding transcripts. Suggestive of non‐canonical roles, pThr4 marked Pol II regulates distinct gene classes in a species‐ and signal‐responsive manner. Hinting at undiscovered roles of this elusive mark, multiple signal‐responsive kinases phosphorylate Thr4 at target genes. Here, we focus on this under‐explored residue and postulate that the pThr4 mark is superimposed on the canonical CTD code to selectively regulate expression of targeted genes without perturbing genome‐wide transcriptional processes. This article is categorized under: RNA Processing > 3′ End Processing RNA Processing > Processing of Small RNAs RNA Processing > Splicing Regulation/Alternative Splicing

Oncoprotein CoAA Repeats Interact with RNA Polymerase II CTD Repeats

Cooperative Interaction of Transcription Termination Factors with the RNA Polymerase II C-terminal Domain.

Variation of C-terminal domain governs RNA polymerase II genomic locations and alternative splicing in eukaryotic transcription

Control of the RNA polymerase II phosphorylation state in promoter regions by CTD interaction domain-containing proteins RPRD1A and RPRD1B

Repression of pervasive antisense transcription is the primary role of fission yeast RNA polymerase II CTD serine 2 phosphorylation

Crosstalk between RNA Pol II C-Terminal Domain Acetylation and Phosphorylation via RPRD Proteins

The RNA Polymerase II C-terminal Domain Promotes Splicing Activation Through Recruitment of a U 2 AF 65 – Prp 19 Complex

The transcriptional coactivator RUVBL2 regulates Pol II clustering with diverse transcription factors

Switched Alternative Splicing of Oncogene CoAA During Embryonal Carcinoma Stem Cell Differentiation.

The RNA Polymerase C-terminal Domain

Comparative Genomics and Evolution of Proteins Associated with RNA Polymerase II C-terminal Domain.

Different Phosphoisoforms Of Rna Polymerase Ii Engage The Rtt103 Termination Factor In A Structurally Analogous Manner

A Positive Feedback Loop Between EBP2 and C-Myc Regulates Rdna Transcription, Cell Proliferation, and Tumorigenesis.

Simplicity is the Ultimate Sophistication—Crosstalk of Post-translational Modifications on the RNA Polymerase II

A Dual Role of Human Trna Methyltransferase Htrmt13 in Regulating Translation and Transcription.

The Phantom Mark: Enigmatic roles of phospho‐Threonine 4 modification of the C‐terminal domain of RNA polymerase II

Rtr1 is a Dual Specificity Phosphatase That Dephosphorylates Tyr1 and Ser5 on the RNA Polymerase II CTD

PAF1C allosterically activates CDK12/13 kinase during RNAPII transcript elongation

Sequence and structural determinants of RNAPII CTD phase-separation and phosphorylation by CDK7

Coordinate control of the RNA polymerase II transcription cycle by CDK9-dependent, tripartite phosphorylation of SPT5